|
|
Nomination Committee appointed for SciBase Holding's Annual General Meeting in 2027 |
|
|
Interim report |
|
|
SciBase has secured first US payer coverage with major insurance company, aims for global lead in non-invasive skin assessment |
|
|
SciBase's EIS Technology Selected as Primary Endpoint in NIH Skin Barrier Study |
|
|
SciBase secures first payer coverage with Highmark, marking a major commercial inflection point |
|
|
SciBase's rights issue registered, conversion of BTA into shares |
|
|
Recalculation of warrants of series TO 2 following rights issue |
|
|
SciBase resolves on a set-off issue of shares to the guarantor in connection with the completed rights issue |
|
|
SciBase announces outcome of rights issue of shares |
|
|
SciBase announces confirmed guarantee commitment in connection with ongoing rights issue |